Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings.
Multidisciplinary evaluation
Non small cell lung cancer
Stage III
Journal
La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
17
07
2019
accepted:
01
10
2019
pubmed:
13
10
2019
medline:
15
2
2020
entrez:
13
10
2019
Statut:
ppublish
Résumé
To report criticisms and barriers to the "real-life" application of international guidelines and recent developments in the management of locally advanced non-small cell lung cancer (NSCLC) in Italy. Three 2-day courses were organized. During the first day, experts in different fields of thoracic oncology gave their lecture on diagnosis and therapy for locally advanced NSCLC. During the second day, all participants were divided into four groups to discuss on a clinical case as a multidisciplinary team (MDT). The aim was to stimulate the discussion on practical issues in the management of NSCLC patients in the real-life practice. A total of 196 physicians were involved in the courses as learners. Invasive diagnosis of nodal disease for staging purposes, a priori definition of "surgical resectability" and a regular MDT with all crucial participants available were the three main key points identified for a good management of these patients. The main barriers to the clinical application of a good diagnostic and therapeutic approach to the patient were the absence of a regular and complete MDT in the South and Centre of Italy, while in the North of Italy, time for discussion of clinical cases in the MDT and waiting lists for staging and therapeutic interventions were deemed as the major concerns. The meetings showed that diagnosis and treatment of locally advanced NSCLC are still extremely variable between different Italian regions. Logistic issues, waiting lists, paucity of well-trained staff and expertise seem to be the main barriers to international guidelines application.
Identifiants
pubmed: 31605353
doi: 10.1007/s11547-019-01094-w
pii: 10.1007/s11547-019-01094-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-219Références
Medicine (Baltimore). 2015 Jun;94(24):e955
pubmed: 26091460
Ann Thorac Surg. 2000 Dec;70(6):1826-31
pubmed: 11156079
Adv Exp Med Biol. 2016;893:1-19
pubmed: 26667336
Cancer. 2014 Dec 1;120 Suppl 23:3781-92
pubmed: 25412390
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Chest. 2013 May;143(5 Suppl):e314S-e340S
pubmed: 23649445
Interact Cardiovasc Thorac Surg. 2016 Apr;22(4):397-400
pubmed: 26810916
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21
pubmed: 28881918
J Clin Oncol. 2014 Aug 20;32(24):2595-603
pubmed: 25071125
Ann Thorac Surg. 2008 Sep;86(3):912-20; discussion 912-20
pubmed: 18721582
Clin Lung Cancer. 2015 Sep;16(5):325-33
pubmed: 25862554
Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1199-1204
pubmed: 29293943
J Clin Oncol. 2010 May 1;28(13):2181-90
pubmed: 20351327